In cancer cells, over-expression of FASLG has been associated with increased risk of cancer progression while that of CD40L has been associated with proliferation and tumor progression, thereby promoting resistance by strengthening immunity [46,47,48,49,50]. Here, CD40LG is linked to cancer.